Print Page  Close Window     


SEC Filings


8-K
VANDA PHARMACEUTICALS INC. filed this Form 8-K on 11/07/2018
Entire Document
 << Previous Page | Next Page >>


VANDA PHARMACEUTICALS INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

(in thousands)

(unaudited)

 

     September 30
2018 (1)
    December 31
2017 (1)
 

ASSETS

    

Current assets:

    

Cash and cash equivalents

   $ 60,778     $ 33,627  

Marketable securities

     179,801       109,786  

Accounts receivable, net

     25,259       17,601  

Inventory

     887       840  

Prepaid expenses and other current assets

     12,082       8,003  
  

 

 

   

 

 

 

Total current assets

     278,807       169,857  

Property and equipment, net

     4,579       5,306  

Intangible assets, net

     24,922       26,069  

Non-current inventory and other

     3,629       4,193  
  

 

 

   

 

 

 

Total assets

   $ 311,937     $ 205,425  
  

 

 

   

 

 

 

LIABILITIES AND STOCKHOLDERS’ EQUITY

    

Current liabilities:

    

Accounts payable and accrued liabilities

   $ 19,046     $ 20,335  

Product revenue allowances

     27,196       23,028  

Milestone obligations under license agreements

     —         27,000  
  

 

 

   

 

 

 

Total current liabilities

     46,242       70,363  

Other non-current liabilities

     4,278       3,675  
  

 

 

   

 

 

 

Total liabilities

     50,520       74,038  

Stockholders’ equity:

    

Common stock

     52       45  

Additional paid-in capital

     607,873       492,802  

Accumulated other comprehensive income (loss)

     70       (34

Accumulated deficit

     (346,578     (361,426
  

 

 

   

 

 

 

Total stockholders’ equity

     261,417       131,387  
  

 

 

   

 

 

 

Total liabilities and stockholders’ equity

   $ 311,937     $ 205,425  
  

 

 

   

 

 

 

 

(1)

With the adoption of Accounting Standards Codification Subtopic 606, Revenue from Contracts with Customers, on January 1, 2018, provision for product returns is included in product revenue allowances and other non-current liabilities in the current year. Provision for product returns is included in accounts receivable, net in the prior year. Please refer to footnote 2 in the quarterly report on Form 10-Q for the quarter ended September 30, 2018, to be filed in the fourth quarter of 2018, for more information.

 

Page 6 of 7

 << Previous Page | Next Page >>